ERNA vs SOFI · P/E 0.0, rev $582.0K vs P/E 39, rev $619.4M
Eterna Therapeutics Inc (ERNA) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported SOFI revenue for 2025-12-31 was $619.4M. Net income was $481.3M. Revenue was up 23.1% from 2024-12-31 to 2025-12-31. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the ERNA and SOFI stock pages for the full models.
Not investment advice.